🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the safety of combination immune therapy in HIV-infected particip...
Status
Withdrawn
Location
University of California
Start Date
2020-01-01
Trial ID
NCT04144335
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-03-19
Trial ID
NCT03387085
This Phase 2 study tests whether adding two immune therapies - nogapendekin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2026-04-15
Trial ID
NCT07492888
Background: Squamous cell carcinoma is a type of cancer that can cause tum...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2025-09-24
Trial ID
NCT06161545
Treatments Being Tested
This is an open-label, phase 1 clinical trial to evaluate the safety and pr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-01
Trial ID
NCT07488884
Open-Label, Phase 2 Chemotherapy-Free Study ofCD19 t-haNK and NAI in Combin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07477366
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Active Not Recruiting
Location
Alabama CRS (Site ID# 31788)
Start Date
2021-05-21
Trial ID
NCT04340596
Treatments Being Tested
This is a Phase I/II, open-label, multi-center, competitive enrollment and ...
Status
Terminated
Location
University of Minnesota Cancer Center
Start Date
2015-04-17
Trial ID
NCT02384954
The proposed study is a phase 1, open label, single arm study to evaluate t...
Status
Completed
Location
Weill Cornell Medicine, Cornell Clinical Trials Unit
Start Date
2022-12-07
Trial ID
NCT05245292
Treatments Being Tested
Background: Endometrial cancer (EC) of the uterus is becoming more common ...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2024-05-14
Trial ID
NCT06253494
Treatments Being Tested